Your browser doesn't support javascript.
loading
Molecular role of the PAX5-ETV6 oncoprotein in promoting B-cell acute lymphoblastic leukemia.
Smeenk, Leonie; Fischer, Maria; Jurado, Sabine; Jaritz, Markus; Azaryan, Anna; Werner, Barbara; Roth, Mareike; Zuber, Johannes; Stanulla, Martin; den Boer, Monique L; Mullighan, Charles G; Strehl, Sabine; Busslinger, Meinrad.
Afiliación
  • Smeenk L; Research Institute of Molecular Pathology (IMP), Vienna Biocenter (VBC), Vienna, Austria.
  • Fischer M; Research Institute of Molecular Pathology (IMP), Vienna Biocenter (VBC), Vienna, Austria.
  • Jurado S; Research Institute of Molecular Pathology (IMP), Vienna Biocenter (VBC), Vienna, Austria.
  • Jaritz M; Research Institute of Molecular Pathology (IMP), Vienna Biocenter (VBC), Vienna, Austria.
  • Azaryan A; Research Institute of Molecular Pathology (IMP), Vienna Biocenter (VBC), Vienna, Austria.
  • Werner B; Research Institute of Molecular Pathology (IMP), Vienna Biocenter (VBC), Vienna, Austria.
  • Roth M; Research Institute of Molecular Pathology (IMP), Vienna Biocenter (VBC), Vienna, Austria.
  • Zuber J; Research Institute of Molecular Pathology (IMP), Vienna Biocenter (VBC), Vienna, Austria.
  • Stanulla M; Pediatric Hematology and Oncology, Hannover Medical School, Hannover, Germany.
  • den Boer ML; Department of Pediatric Oncology and Hematology, Erasmus Medical Center, Sophia Children Hospital, Rotterdam, The Netherlands.
  • Mullighan CG; Department of Pathology, St. Jude Children's Research Hospital, Memphis, TN, USA.
  • Strehl S; Children's Cancer Research Institute, St. Anna Kinderkrebsforschung e.V., Vienna, Austria.
  • Busslinger M; Research Institute of Molecular Pathology (IMP), Vienna Biocenter (VBC), Vienna, Austria busslinger@imp.ac.at.
EMBO J ; 36(6): 718-735, 2017 03 15.
Article en En | MEDLINE | ID: mdl-28219927
ABSTRACT
PAX5 is a tumor suppressor in B-ALL, while the role of PAX5 fusion proteins in B-ALL development is largely unknown. Here, we studied the function of PAX5-ETV6 and PAX5-FOXP1 in mice expressing these proteins from the Pax5 locus. Both proteins arrested B-lymphopoiesis at the pro-B to pre-B-cell transition and, contrary to their proposed dominant-negative role, did not interfere with the expression of most regulated Pax5 target genes. Pax5-Etv6, but not Pax5-Foxp1, cooperated with loss of the Cdkna2a/b tumor suppressors in promoting B-ALL development. Regulated Pax5-Etv6 target genes identified in these B-ALLs encode proteins implicated in pre-B-cell receptor (BCR) signaling and migration/adhesion, which could contribute to the proliferation, survival, and tissue infiltration of leukemic B cells. Together with similar observations made in human PAX5-ETV6+ B-ALLs, these data identified PAX5-ETV6 as a potent oncoprotein that drives B-cell leukemia development.
Asunto(s)
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Proteínas Represoras / Proteínas Recombinantes de Fusión / Leucemia-Linfoma Linfoblástico de Células Precursoras B / Proteínas Oncogénicas / Factor de Transcripción PAX5 / Proteínas Proto-Oncogénicas c-ets Tipo de estudio: Prognostic_studies Límite: Animals Idioma: En Revista: EMBO J Año: 2017 Tipo del documento: Article País de afiliación: Austria

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Proteínas Represoras / Proteínas Recombinantes de Fusión / Leucemia-Linfoma Linfoblástico de Células Precursoras B / Proteínas Oncogénicas / Factor de Transcripción PAX5 / Proteínas Proto-Oncogénicas c-ets Tipo de estudio: Prognostic_studies Límite: Animals Idioma: En Revista: EMBO J Año: 2017 Tipo del documento: Article País de afiliación: Austria